ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 226.00K | 225.00K | 217.00K | 221.00K | 230.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 226.00K | 225.00K | 217.00K | 221.00K | 230.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 226.00K | 225.00K | 217.00K | 221.00K | 230.00K |
| SG&A Expenses | 11.32M | 11.76M | 11.62M | 14.05M | 14.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.16M | 45.91M | 38.44M | 39.93M | 41.62M |
| Operating Income | -44.93M | -45.69M | -38.22M | -39.71M | -41.39M |
| Income Before Tax | -42.62M | -42.44M | -35.28M | -36.12M | -37.36M |
| Income Tax Expenses | -- | -1.59M | 560.00K | 848.00K | 591.00K |
| Earnings from Continuing Operations | -42.62M | -40.85M | -35.84M | -36.97M | -37.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.58M | 21.62M | 19.37M | 20.41M | 21.22M |
| Net Income | -20.04M | -19.23M | -16.47M | -16.55M | -16.73M |
| EBIT | -44.93M | -45.69M | -38.22M | -39.71M | -41.39M |
| EBITDA | -43.28M | -43.85M | -36.55M | -38.24M | -39.79M |
| EPS Basic | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.14 | -0.14 | -0.12 | -0.13 | -0.13 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 141.93M | 141.00M | 134.99M | 130.73M | 126.98M |
| Average Diluted Shares Outstanding | 141.93M | 141.00M | 134.99M | 130.73M | 126.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |